Group One Trading, L.P. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.11 - $5.46 $352 - $17,472	-3,200 Reduced 2.41%	129,411 $14,000
Q3 2022 Nov 09, 2022	SELL	$0.17 - $5.31 $1,309 - $40,887	-7,700 Reduced 5.49%	132,611 $22,000
Q2 2022 Aug 11, 2022	BUY	$0.21 - $0.53 $3,024 - $7,632	14,400 Added 11.44%	140,311 $35,000
Q1 2022 May 12, 2022	SELL	$0.32 - $0.67 $17,304 - $36,230	-54,076 Reduced 30.04%	125,911 $67,000
Q4 2021 Feb 11, 2022	BUY	$0.6 - $1.11 $23,410 - $43,308	39,017 Added 27.68%	179,987 $111,000
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.82 $60,802 - $109,564	60,200 Added 74.53%	140,970 $144,000
Q2 2021 Aug 10, 2021	SELL	$1.39 - $2.21 $72,149 - $114,712	-51,906 Reduced 39.12%	80,770 $148,000
Q1 2021 May 12, 2021	SELL	$1.27 - $3.42 $22,783 - $61,354	-17,940 Reduced 11.91%	132,676 $261,000
Q4 2020 Feb 10, 2021	SELL	$0.94 - $1.89 $362,876 - $729,613	-386,039 Reduced 71.93%	150,616 $188,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $9.38 $660,517 - $4.13 Million	440,345 Added 457.22%	536,655 $966,000
Q2 2020 Aug 13, 2020	SELL	$4.79 - $8.39 $218,007 - $381,854	-45,513 Reduced 32.09%	96,310 $808,000
Q1 2020 May 13, 2020	BUY	$3.44 - $7.21 $350,622 - $734,879	101,925 Added 255.46%	141,823 $743,000
Q4 2019 Feb 10, 2020	BUY	$4.29 - $5.64 $429 - $564	100 Added 0.25%	39,898 $218,000
Q3 2019 Nov 12, 2019	SELL	$4.87 - $7.08 $69,704 - $101,336	-14,313 Reduced 26.45%	39,798 $194,000
Q2 2019 Aug 09, 2019	SELL	$6.6 - $7.8 $260,911 - $308,349	-39,532 Reduced 42.22%	54,111 $375,000
Q1 2019 May 13, 2019	BUY	$5.76 - $8.95 $223,234 - $346,866	38,756 Added 70.61%	93,643 $651,000
Q4 2018 Feb 06, 2019	BUY	$5.26 - $7.97 $208,448 - $315,843	39,629 Added 259.73%	54,887 $321,000
Q3 2018 Nov 08, 2018	BUY	$4.65 - $7.95 $33,312 - $56,953	7,164 Added 88.51%	15,258 $115,000
Q2 2018 Aug 14, 2018	SELL	$5.05 - $6.8 $82,158 - $110,629	-16,269 Reduced 66.78%	8,094 $41,000
Q1 2018 May 11, 2018	SELL	$5.6 - $9.25 $230,652 - $380,989	-41,188 Reduced 62.83%	24,363 $149,000
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $143,451 - $169,098	21,735 Added 49.61%	65,551 $465,000
Q3 2017 Nov 15, 2017	BUY	$5.75 - $7.75 $166,324 - $224,176	28,926 Added 194.26%	43,816 $313,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,890	14,890 $94,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account